nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLCO1A2—Prednisolone—ankylosing spondylitis	0.117	0.12	CbGbCtD
Bumetanide—PTGS2—Sulfasalazine—ankylosing spondylitis	0.114	0.116	CbGbCtD
Bumetanide—PTGS2—Triamcinolone—ankylosing spondylitis	0.114	0.116	CbGbCtD
Bumetanide—SLCO1A2—Prednisone—ankylosing spondylitis	0.111	0.113	CbGbCtD
Bumetanide—PTGS2—Betamethasone—ankylosing spondylitis	0.0974	0.0995	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—ankylosing spondylitis	0.0832	0.085	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—ankylosing spondylitis	0.0793	0.081	CbGbCtD
Bumetanide—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0692	0.0707	CbGbCtD
Bumetanide—PTGS2—Dexamethasone—ankylosing spondylitis	0.0567	0.0579	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0556	0.0568	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—ankylosing spondylitis	0.0484	0.0495	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—ankylosing spondylitis	0.0337	0.0345	CbGbCtD
Bumetanide—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.00116	0.159	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.00114	0.156	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.00114	0.156	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.00112	0.153	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000701	0.0958	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.00069	0.0943	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.00069	0.0943	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000674	0.0921	CbGdCrCtD
Bumetanide—Electrolyte imbalance—Methylprednisolone—ankylosing spondylitis	0.000629	0.0456	CcSEcCtD
Bumetanide—Electrolyte imbalance—Betamethasone—ankylosing spondylitis	0.000572	0.0415	CcSEcCtD
Bumetanide—Electrolyte imbalance—Dexamethasone—ankylosing spondylitis	0.000572	0.0415	CcSEcCtD
Bumetanide—Azotaemia—Methotrexate—ankylosing spondylitis	0.000326	0.0237	CcSEcCtD
Bumetanide—Glycosuria—Triamcinolone—ankylosing spondylitis	0.000325	0.0236	CcSEcCtD
Bumetanide—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.000324	0.0235	CcSEcCtD
Bumetanide—Glycosuria—Dexamethasone—ankylosing spondylitis	0.000295	0.0214	CcSEcCtD
Bumetanide—Glycosuria—Betamethasone—ankylosing spondylitis	0.000295	0.0214	CcSEcCtD
Bumetanide—Encephalopathy—Methotrexate—ankylosing spondylitis	0.000271	0.0197	CcSEcCtD
Bumetanide—Glycosuria—Prednisone—ankylosing spondylitis	0.000257	0.0186	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.000187	0.0136	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.000177	0.0129	CcSEcCtD
Bumetanide—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000176	0.0128	CcSEcCtD
Bumetanide—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000162	0.0118	CcSEcCtD
Bumetanide—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000162	0.0117	CcSEcCtD
Bumetanide—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000158	0.0115	CcSEcCtD
Bumetanide—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000158	0.0115	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.000156	0.0113	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—ankylosing spondylitis	0.000144	0.0104	CcSEcCtD
Bumetanide—Sweating—Methylprednisolone—ankylosing spondylitis	0.000141	0.0102	CcSEcCtD
Bumetanide—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000137	0.00998	CcSEcCtD
Bumetanide—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000135	0.00981	CcSEcCtD
Bumetanide—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000135	0.00981	CcSEcCtD
Bumetanide—Pancreatitis—Prednisone—ankylosing spondylitis	0.000128	0.00929	CcSEcCtD
Bumetanide—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000118	0.00855	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000114	0.00825	CcSEcCtD
Bumetanide—Vertigo—Prednisolone—ankylosing spondylitis	0.000112	0.00816	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000107	0.00776	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000105	0.00759	CcSEcCtD
Bumetanide—Vertigo—Triamcinolone—ankylosing spondylitis	0.000103	0.00751	CcSEcCtD
Bumetanide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000103	0.00749	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	9.87e-05	0.00717	CcSEcCtD
Bumetanide—Arthralgia—Methylprednisolone—ankylosing spondylitis	9.78e-05	0.0071	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	9.64e-05	0.007	CcSEcCtD
Bumetanide—Dry mouth—Triamcinolone—ankylosing spondylitis	9.58e-05	0.00696	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—ankylosing spondylitis	9.56e-05	0.00694	CcSEcCtD
Bumetanide—Vertigo—Betamethasone—ankylosing spondylitis	9.38e-05	0.00681	CcSEcCtD
Bumetanide—Vertigo—Dexamethasone—ankylosing spondylitis	9.38e-05	0.00681	CcSEcCtD
Bumetanide—Sweating—Methotrexate—ankylosing spondylitis	9.32e-05	0.00677	CcSEcCtD
Bumetanide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	9.08e-05	0.00659	CcSEcCtD
Bumetanide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	9.06e-05	0.00658	CcSEcCtD
Bumetanide—Hypotension—Methylprednisolone—ankylosing spondylitis	8.76e-05	0.00636	CcSEcCtD
Bumetanide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	8.34e-05	0.00606	CcSEcCtD
Bumetanide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	8.34e-05	0.00606	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—ankylosing spondylitis	8.25e-05	0.00599	CcSEcCtD
Bumetanide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	8.24e-05	0.00598	CcSEcCtD
Bumetanide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	8.24e-05	0.00598	CcSEcCtD
Bumetanide—Vertigo—Prednisone—ankylosing spondylitis	8.17e-05	0.00593	CcSEcCtD
Bumetanide—Urticaria—Prednisolone—ankylosing spondylitis	8.11e-05	0.00589	CcSEcCtD
Bumetanide—Fatigue—Triamcinolone—ankylosing spondylitis	8.1e-05	0.00588	CcSEcCtD
Bumetanide—Fatigue—Methylprednisolone—ankylosing spondylitis	8.08e-05	0.00587	CcSEcCtD
Bumetanide—Hypotension—Betamethasone—ankylosing spondylitis	7.96e-05	0.00578	CcSEcCtD
Bumetanide—Hypotension—Dexamethasone—ankylosing spondylitis	7.96e-05	0.00578	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—ankylosing spondylitis	7.74e-05	0.00562	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	7.66e-05	0.00556	CcSEcCtD
Bumetanide—Urticaria—Triamcinolone—ankylosing spondylitis	7.46e-05	0.00542	CcSEcCtD
Bumetanide—Urticaria—Methylprednisolone—ankylosing spondylitis	7.44e-05	0.0054	CcSEcCtD
Bumetanide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	7.41e-05	0.00538	CcSEcCtD
Bumetanide—Fatigue—Betamethasone—ankylosing spondylitis	7.35e-05	0.00533	CcSEcCtD
Bumetanide—Fatigue—Dexamethasone—ankylosing spondylitis	7.35e-05	0.00533	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisone—ankylosing spondylitis	7.17e-05	0.00521	CcSEcCtD
Bumetanide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	6.97e-05	0.00506	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	6.97e-05	0.00506	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—ankylosing spondylitis	6.83e-05	0.00496	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—ankylosing spondylitis	6.8e-05	0.00494	CcSEcCtD
Bumetanide—Urticaria—Betamethasone—ankylosing spondylitis	6.77e-05	0.00491	CcSEcCtD
Bumetanide—Urticaria—Dexamethasone—ankylosing spondylitis	6.77e-05	0.00491	CcSEcCtD
Bumetanide—Dizziness—Prednisolone—ankylosing spondylitis	6.75e-05	0.0049	CcSEcCtD
Bumetanide—Asthenia—Triamcinolone—ankylosing spondylitis	6.74e-05	0.00489	CcSEcCtD
Bumetanide—Abdominal pain—Dexamethasone—ankylosing spondylitis	6.74e-05	0.00489	CcSEcCtD
Bumetanide—Abdominal pain—Betamethasone—ankylosing spondylitis	6.74e-05	0.00489	CcSEcCtD
Bumetanide—Asthenia—Methylprednisolone—ankylosing spondylitis	6.72e-05	0.00488	CcSEcCtD
Bumetanide—Pruritus—Triamcinolone—ankylosing spondylitis	6.64e-05	0.00482	CcSEcCtD
Bumetanide—Pruritus—Methylprednisolone—ankylosing spondylitis	6.63e-05	0.00481	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—ankylosing spondylitis	6.47e-05	0.0047	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—ankylosing spondylitis	6.47e-05	0.0047	CcSEcCtD
Bumetanide—Rash—Prednisolone—ankylosing spondylitis	6.44e-05	0.00467	CcSEcCtD
Bumetanide—Dermatitis—Prednisolone—ankylosing spondylitis	6.43e-05	0.00467	CcSEcCtD
Bumetanide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	6.41e-05	0.00465	CcSEcCtD
Bumetanide—Fatigue—Prednisone—ankylosing spondylitis	6.4e-05	0.00464	CcSEcCtD
Bumetanide—Headache—Prednisolone—ankylosing spondylitis	6.4e-05	0.00464	CcSEcCtD
Bumetanide—Dizziness—Triamcinolone—ankylosing spondylitis	6.21e-05	0.00451	CcSEcCtD
Bumetanide—Dizziness—Methylprednisolone—ankylosing spondylitis	6.2e-05	0.0045	CcSEcCtD
Bumetanide—Asthenia—Betamethasone—ankylosing spondylitis	6.11e-05	0.00444	CcSEcCtD
Bumetanide—Asthenia—Dexamethasone—ankylosing spondylitis	6.11e-05	0.00444	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.07e-05	0.00441	CcSEcCtD
Bumetanide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	6.07e-05	0.00441	CcSEcCtD
Bumetanide—Nausea—Prednisolone—ankylosing spondylitis	6.07e-05	0.0044	CcSEcCtD
Bumetanide—Pruritus—Dexamethasone—ankylosing spondylitis	6.03e-05	0.00438	CcSEcCtD
Bumetanide—Pruritus—Betamethasone—ankylosing spondylitis	6.03e-05	0.00438	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6e-05	0.00435	CcSEcCtD
Bumetanide—Vomiting—Triamcinolone—ankylosing spondylitis	5.97e-05	0.00433	CcSEcCtD
Bumetanide—Vomiting—Methylprednisolone—ankylosing spondylitis	5.96e-05	0.00433	CcSEcCtD
Bumetanide—Rash—Triamcinolone—ankylosing spondylitis	5.92e-05	0.0043	CcSEcCtD
Bumetanide—Dermatitis—Triamcinolone—ankylosing spondylitis	5.92e-05	0.00429	CcSEcCtD
Bumetanide—Rash—Methylprednisolone—ankylosing spondylitis	5.91e-05	0.00429	CcSEcCtD
Bumetanide—Dermatitis—Methylprednisolone—ankylosing spondylitis	5.9e-05	0.00429	CcSEcCtD
Bumetanide—Urticaria—Prednisone—ankylosing spondylitis	5.9e-05	0.00428	CcSEcCtD
Bumetanide—Headache—Triamcinolone—ankylosing spondylitis	5.88e-05	0.00427	CcSEcCtD
Bumetanide—Headache—Methylprednisolone—ankylosing spondylitis	5.87e-05	0.00426	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—ankylosing spondylitis	5.87e-05	0.00426	CcSEcCtD
Bumetanide—Diarrhoea—Betamethasone—ankylosing spondylitis	5.83e-05	0.00423	CcSEcCtD
Bumetanide—Diarrhoea—Dexamethasone—ankylosing spondylitis	5.83e-05	0.00423	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—ankylosing spondylitis	5.8e-05	0.00421	CcSEcCtD
Bumetanide—Dizziness—Dexamethasone—ankylosing spondylitis	5.64e-05	0.00409	CcSEcCtD
Bumetanide—Dizziness—Betamethasone—ankylosing spondylitis	5.64e-05	0.00409	CcSEcCtD
Bumetanide—Nausea—Triamcinolone—ankylosing spondylitis	5.58e-05	0.00405	CcSEcCtD
Bumetanide—Nausea—Methylprednisolone—ankylosing spondylitis	5.57e-05	0.00404	CcSEcCtD
Bumetanide—Vomiting—Betamethasone—ankylosing spondylitis	5.42e-05	0.00393	CcSEcCtD
Bumetanide—Vomiting—Dexamethasone—ankylosing spondylitis	5.42e-05	0.00393	CcSEcCtD
Bumetanide—Rash—Betamethasone—ankylosing spondylitis	5.37e-05	0.0039	CcSEcCtD
Bumetanide—Rash—Dexamethasone—ankylosing spondylitis	5.37e-05	0.0039	CcSEcCtD
Bumetanide—Dermatitis—Betamethasone—ankylosing spondylitis	5.37e-05	0.0039	CcSEcCtD
Bumetanide—Dermatitis—Dexamethasone—ankylosing spondylitis	5.37e-05	0.0039	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—ankylosing spondylitis	5.35e-05	0.00388	CcSEcCtD
Bumetanide—Headache—Dexamethasone—ankylosing spondylitis	5.34e-05	0.00388	CcSEcCtD
Bumetanide—Headache—Betamethasone—ankylosing spondylitis	5.34e-05	0.00388	CcSEcCtD
Bumetanide—Asthenia—Prednisone—ankylosing spondylitis	5.32e-05	0.00387	CcSEcCtD
Bumetanide—Pruritus—Prednisone—ankylosing spondylitis	5.25e-05	0.00381	CcSEcCtD
Bumetanide—Diarrhoea—Prednisone—ankylosing spondylitis	5.08e-05	0.00369	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	5.07e-05	0.00368	CcSEcCtD
Bumetanide—Nausea—Dexamethasone—ankylosing spondylitis	5.06e-05	0.00367	CcSEcCtD
Bumetanide—Nausea—Betamethasone—ankylosing spondylitis	5.06e-05	0.00367	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—ankylosing spondylitis	4.93e-05	0.00358	CcSEcCtD
Bumetanide—Dizziness—Prednisone—ankylosing spondylitis	4.91e-05	0.00356	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—ankylosing spondylitis	4.9e-05	0.00356	CcSEcCtD
Bumetanide—Vomiting—Prednisone—ankylosing spondylitis	4.72e-05	0.00343	CcSEcCtD
Bumetanide—Rash—Prednisone—ankylosing spondylitis	4.68e-05	0.0034	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—ankylosing spondylitis	4.67e-05	0.00339	CcSEcCtD
Bumetanide—Headache—Prednisone—ankylosing spondylitis	4.65e-05	0.00338	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—ankylosing spondylitis	4.45e-05	0.00323	CcSEcCtD
Bumetanide—Nausea—Prednisone—ankylosing spondylitis	4.41e-05	0.0032	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—ankylosing spondylitis	4.39e-05	0.00319	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—ankylosing spondylitis	4.24e-05	0.00308	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—ankylosing spondylitis	4.1e-05	0.00298	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—ankylosing spondylitis	3.94e-05	0.00286	CcSEcCtD
Bumetanide—Rash—Methotrexate—ankylosing spondylitis	3.91e-05	0.00284	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—ankylosing spondylitis	3.91e-05	0.00284	CcSEcCtD
Bumetanide—Headache—Methotrexate—ankylosing spondylitis	3.89e-05	0.00282	CcSEcCtD
Bumetanide—Nausea—Methotrexate—ankylosing spondylitis	3.68e-05	0.00267	CcSEcCtD
